Heidi Ayap, MD
Pediatrics · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ayap’s office at (408) 272-6300 to ask if they take your plan before you enroll.
California Medical Board record
Licence A52631 · Current
Licensed to practise in California · since 1993 · expires 2027-01-31 · Cebu Institute of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$21,582 in 2023
Medicaid paid $21,582 for 1,332 billed services this clinician did in 2023, up to 41 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| LIMITED VISUAL FIELD XM UNI/BI I&R | 278 | $9,882 |
| Pure tone audiometry (threshold); air only | 275 | $4,919 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 58 | $3,385 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 40 | $1,837 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 92 | $838 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 73 | $387 |
| Screening performed and negative | 310 | $334 |
| Short return visit (20+ min) | 206 | $0 |
| 2023 | 1,332 | 8 | 41 | $21,582 |
| 2022 | 1,272 | 9 | 52 | $21,366 |
| 2021 | 1,211 | 8 | 68 | $23,145 |
| 2020 | 1,644 | 16 | 62 | $54,602 |
| 2019 | 2,043 | 11 | 57 | $84,685 |
| 2018 | 1,284 | 13 | 70 | $71,379 |
See the largest Medicaid services in earlier years
2022
| LIMITED VISUAL FIELD XM UNI/BI I&R | 310 | $9,773 |
| Pure tone audiometry (threshold); air only | 309 | $4,884 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 97 | $4,715 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 26 | $967 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 80 | $690 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 29 | $208 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 15 | $99 |
| Screening performed and negative | 132 | $30 |
| Short return visit (20+ min) | 274 | $0 |
2021
| LIMITED VISUAL FIELD XM UNI/BI I&R | 303 | $8,865 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 104 | $4,957 |
| Pure tone audiometry (threshold); air only | 303 | $4,459 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 68 | $2,997 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 142 | $1,106 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $453 |
| Short return visit (20+ min) | 259 | $159 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 20 | $149 |
2020
| Clinic visit/encounter, all-inclusive | 158 | $31,168 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 321 | $8,269 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 111 | $4,957 |
| Pure tone audiometry (threshold); air only | 325 | $4,627 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 93 | $3,722 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 103 | $932 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 14 | $371 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 31 | $208 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 15 | $129 |
| Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use | 14 | $109 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 13 | $109 |
| HEMOGLOBIN | 46 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 449 | $73,670 |
| Pure tone audiometry (threshold); air only | 279 | $3,166 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 274 | $3,096 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 43 | $1,760 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 45 | $1,533 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 126 | $883 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 19 | $577 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 19 | $0 |
| HEMOGLOBIN | 118 | $0 |
| Bilateral quantitative screening test of visual acuity | 53 | $0 |
| Short return visit (20+ min) | 618 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 405 | $64,047 |
| Pure tone audiometry (threshold); air only | 142 | $1,980 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 130 | $1,800 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 31 | $1,650 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 103 | $813 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 12 | $554 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 13 | $412 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 14 | $99 |
| Short return visit (20+ min) | 370 | $24 |
| HEMOGLOBIN | 27 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $0 |
| Screening test, pure tone, air only | 12 | $0 |
Money from drug and device companies
$21 in 2019
A payment is not proof that care is biased.
| Sanofi Pasteur | Quadracel | $21 | 1 payment
|
See the published payment
| Sanofi Pasteur | Meals · 2019-07-22 | Quadracel | $21 |
Professional record
- NPI
- 1487680898
- Licence
- CA A52631California A52631: Current · expires 2027-01-31
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 55 E Julian St, Attn: Medical Administration, San Jose, CA, 95112
- NPI first listed
- 2006-06-25
- NPI last updated
- 2010-12-29
This is when the NPI record was last certified, not a medical board exam.